Bluejay Diagnostics, Inc. (NasdaqCM: BJDX)
Health Care · Health Care Equipment & Supplies · US
$0.94
+2.98% today · -84.0% 1Y
Bluejay Diagnostics, Inc. (NasdaqCM: BJDX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $4.07M and employs 6 people.
Over the last twelve months the share price has lost 84.0%, trading between 0.83 and 16.68.
Tweenvest scores Bluejay Diagnostics, Inc. across four factors: quality 26/100. Its strongest factor is quality.
BJDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.07M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -6.65
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- $16.68
- 52-week low
- $0.83
- Avg volume (3M)
- —
- Shares outstanding
- 4.47M
- Employees
- 6
- Next earnings
- —
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
- ISIN
- US0956336087
- Founded
- 2015
- Listed since
- Nov 10, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.82 | -0.27% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.72 | -0.03% |
| Stryker CorporationNYSE: SYK | $126.81B | $332.00 | +0.43% |
| Medtronic plcNYSE: MDT | $116.66B | $91.23 | +0.10% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.14 | -5.46% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.